Dinoy, Jeralyen M.

HRN: 28-63-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
AMPICILLIN 1GM (VIAL)
04/17/2026
04/19/2026
IVTT
2g
Q6h
PROM, Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: